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Protein-driven RNA nanostructured devices that
function in vitro and control mammalian cell fate
Tomonori Shibata1, Yoshihiko Fujita1, Hirohisa Ohno1, Yuki Suzuki2,5, Karin Hayashi1, Kaoru R. Komatsu1,
Shunsuke Kawasaki1, Kumi Hidaka2, Shin Yonehara 3, Hiroshi Sugiyama2,4, Masayuki Endo2,4 & Hirohide Saito1
Nucleic acid nanotechnology has great potential for future therapeutic applications. However,
the construction of nanostructured devices that control cell fate by detecting and amplifying
protein signals has remained a challenge. Here we design and build protein-driven RNA-
nanostructured devices that actuate in vitro by RNA-binding-protein-inducible conforma-
tional change and regulate mammalian cell fate by RNA–protein interaction-mediated protein
assembly. The conformation and function of the RNA nanostructures are dynamically
controlled by RNA-binding protein signals. The protein-responsive RNA nanodevices are
constructed inside cells using RNA-only delivery, which may provide a safe tool for building
functional RNA–protein nanostructures. Moreover, the designed RNA scaffolds that control
the assembly and oligomerization of apoptosis-regulatory proteins on a nanometre scale
selectively kill target cells via speciﬁc RNA–protein interactions. These ﬁndings suggest that
synthetic RNA nanodevices could function as molecular robots that detect signals and
localize target proteins, induce RNA conformational changes, and programme mammalian
cellular behaviour.
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In the nucleic acid nanotechnology ﬁeld, a variety of nanos-tructures have been designed and constructed to utilize theprogrammable features of nucleic acids and the deﬁned size
and periodicity of the double-helical structure1, 2. From this ﬁeld,
the concept of ‘nanomachine3’ or ‘molecular robots4’ has been
investigated, because nucleic acids have the potential to change
their conformations and functions based on the principle of
simple Watson–Crick base pairing. For example, dynamic DNA
nanostructures, such as the DNA walker5, the DNA motor6 and
the DNA nanomachine7–9, have been constructed using
DNA–DNA interactions. For biological applications, it is
important to develop functional nanodevices that detect various
environmental signals (e.g., RNA or protein signals), induce
structural changes and produce desired functions (e.g., control
mammalian cell fate). Several DNA nanostructures have been
generated for potential biomedical and biotechnology applica-
tions, such as target cell-surface detection10, 11, imaging12, 13,
drug delivery14, 15 and chemical reaction control16. For example,
a DNA-based nanorobot has been designed to detect cancer cell-
surface receptors and release a drug in target cells10. Stimuli-
responsive DNA nanohydrogels with size-controllable proper-
ties17 and pH- or chloride-sensing DNA nanodevices have been
constructed inside cells18, 19. In addition to DNA, RNA has
attracted the attention of bioengineers because of the structural
diversity of RNA molecules (i.e., structured RNA uses both
canonical Watson–Crick base pairing and non-canonical RNA
structural motifs to form various two-dimensional and three-
dimensional (3D) structures)20, 21. Several RNA nanostructures,
such as triangles, squares, nanorings, three-way junctions and
prisms, have been constructed in vitro22–35 and some have been
used for cellular applications through the attachment of a func-
tional molecule, such as RNA (e.g., siRNA or aptamer)25, 27, 28, 32
or protein (e.g., cell-surface binder)26, 27, 31–34, on the designed
RNA structures. Synthetic RNA scaffolds that control the
assembly of enzymes for hydrogen production in bacteria have
also been reported26. However, the construction of nanos-
tructured devices that control mammalian cellular behaviour by
detecting or accumulating intracellular protein signals has not yet
been demonstrated.
Inside a cell, many RNA molecules cannot function alone.
RNA molecules together with RNA-binding proteins construct
nanostructured RNA–protein (RNP) complexes. For example, the
ribosome, which is composed of ribosomal RNAs and proteins,
is a nature-made, sophisticated RNP nanomachine that catalyses
protein synthesis based on the information coded in genes.
Clustered regularly interspaced short palindromic repeat-
CRISPR-associated proteins (CRISPR-Cas9) are another exam-
ple of RNP complex-mediated nanodevices that enable the editing
of a target region of genomes in a customized manner36. Several
long noncoding RNAs have been shown to function as natural
scaffolds that can control the localization and function of chro-
matin regulatory proteins37. The naturally occurring RNP inter-
actions often control a variety of biological functions through
dynamic regulation of the structures and activities of intracellular
RNA or protein. Thus, we considered building synthetic RNP
nanostructured devices by mimicking natural RNP complexes
that have the following properties: (1) RNA-nanostructured
devices detect and localize target RNA-binding proteins both
in vitro and inside cells; (2) the conformation of the RNA devices
is dynamically changed through speciﬁc RNP interactions; and
(3) the actuation of the RNA devices produces functional outputs
dependent on the extracellular and intracellular environment.
Here we report protein-driven RNA nanostructured devices
that function in vitro and within live mammalian cells. Speciﬁc
RNP interactions induce both structural and functional changes
in the RNA nanodevices. The actuated RNA devices produce
various outputs, such as the activation and repression of RNA
aptamers (Fig. 1a, b) and the detection of RNA-binding protein in
cells (Fig. 1c). In addition, synthetic RNA scaffolds formed in
mammalian cells can selectively control cell-death pathways by
detecting endogenous RNA-binding protein or microRNA
(miRNA) signals and regulating the assembly and oligomeriza-
tion of apoptosis-regulatory proteins on a nanometre scale
(Fig. 1d).
Results
Construction of protein-driven RNA nanodevices in vitro. To
design protein-responsive RNA nanodevices that induce dynamic
conformational change, we employed the box C/D kink-turn
(K-turn) RNA and a small RNA-binding protein from archaea,
called L7Ae, as an appropriate RNP interaction motif38. The
K-turn adopts a ﬂexible conformation in a protein-free state,
whereas L7Ae strongly stabilizes the K-turn with an approxi-
mately 60° bending angle. We have previously designed triangle-
like RNP nanostructures in vitro using three K-turn-L7Ae motifs
inserted into three vertexes of nanostructures composed of
double-stranded RNAs31–33. However, it has remained a chal-
lenge (1) to induce both dynamic conformational and functional
changes in RNA-nanostructured devices in response to a protein
signal and (2) to construct protein-driven, functional RNA
nanostructures inside mammalian cells.
To induce an apparent conformational change via the RNP
interaction, we designed two RNA strands (long (L) and short (S)
strands) in which Watson–Crick base pairs are formed within the
strands but where the two ends of the double-stranded RNA do
not interact with each other (Fig. 2a; protein-free double-stranded
RNAs should form open, nearly linear structures). We designed
two different types of RNP nanostructures that formed ‘triangle
instrument’-like (Tri-shape; L7Ae bends two K-turn motifs to
place the two ends of the double-stranded RNA close to each
other) or ‘Z-shape’-like nanostructures (Z-shape; L7Ae bends two
K-turn motifs in opposite directions; Figs 1a and 2a). To design
the Tri-shape and Z-shape nanostructures, we incorporated two
K-turn motifs into the 33 and 28 base pairs of 3 RNA duplexes
corresponding to 3 and 2.5 (two and a half) helical turns,
respectively (Supplementary Figs 1 and 2; 2Kt-33-Tri and
2Kt-28-Z). Through the L7Ae-induced conformational change,
2Kt-33-Tri and 2Kt-28-Z should form Tri-shape and Z-shape
nanostructures. These structures enable nanometre-scale control
of the distance between the RNA termini (Fig. 2a, red arrows).
We ﬁrst examined the interaction of L7Ae with 2Kt-33-Tri and
with 2Kt-28-Z using an electrophoretic mobility shift assay
(EMSA; Fig. 2b, c). Both 2Kt-33-Tri and 2Kt-28-Z interacted with
L7Ae in a concentration-dependent manner to give shifted bands,
whereas defective K-turn (dKt)-containing RNA variants that
were designed to be less capable of binding to L7Ae (2dKt-33-Tri
and 2dKt-28-Z; Supplementary Figs 1 and 2)38 provided no
retarded bands (Supplementary Fig. 3), suggesting that two L7Ae
proteins bind to two K-turn motifs in 2Kt-33-Tri and 2Kt-28-Z.
We next analysed the structural changes of 2Kt-33-Tri and 2Kt-
28-Z in the absence and presence of L7Ae by atomic force
microscopy (AFM; Fig. 2d, e). In the absence of L7Ae, 2Kt-33-Tri
and 2Kt-28-Z adopted heterogeneous, nearly linear RNA
structures due to the ﬂexibility of RNA and the lack of interaction
between the two edges of the two RNA strands. In contrast, in
the presence of L7Ae, we observed a conformational change in
2Kt-33-Tri and 2Kt-28-Z: we found that the opened, nearly linear
RNA structures were dynamically changed to Tri-shape- and
Z-shape-like forms due to the two L7Ae-K-turn interactions on
2Kt-33-Tri and 2Kt-28-Z, respectively, which were observed at a
resolution of a single RNP interaction by AFM (Fig. 2d, e and
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Supplementary Fig. 4). These results indicated that two L7Ae
proteins bound to two K-turn motifs of the RNA nanostructures
and induced the RNA conformational change, as expected.
To further analyse the structural change caused by the RNP
interaction, we measured the distance between the two ends of
2Kt-33-Tri and 2Kt-28-Z (shown in red arrows in Fig. 2a) in the
absence and presence of L7Ae (Fig. 2f, g). In the absence of L7Ae,
the edge distance of 2Kt-33-Tri was widely distributed from 0 to
44 nm. In contrast, the addition of L7Ae narrowed the
distribution of the distance (the major population was within
16 nm), because the two ends of 2Kt-33-Tri came close to each
other due to the two L7Ae-K-turn interactions that bent the RNA
at the two K-turn regions to give a Tri-like shape as the major
population (Fig. 2f). Similarly, we observed a distribution change
in the distance between the two ends of 2Kt-28-Z in the absence
and presence of L7Ae (the average distance was ~21 nm; Fig. 2g),
which was consistent with the expected distance from the 3D
modelling of 2Kt-28-Z (~18 nm in the presence of L7Ae).
Conformational changes that regulate the distance between the
two ends of structured RNAs support our concept, i.e., that we
can control the distance and arrangement of RNA-conjugated
molecules on the two edges through protein sensing as an input
signal. To conﬁrm our idea, we attached ﬂuorescent Cy3 and
Cy5 molecules to the edge of 2Kt-33-Tri and analysed the
L7Ae-induced RNA conformational change using Förster
resonance energy transfer (FRET; Supplementary Figs 5 and 6).
We observed an increased ﬂuorescence signal (F665/F565) of
2Kt-33-Tri in the presence of L7Ae, but we did not observe this
signal for the defective RNA, 2dKt-33-Tri, suggesting that FRET
occurred likely due to the structural transition of 2Kt-33-Tri
induced by the L7Ae-K-turn interaction.
ON/OFF switching of RNA function by changing the RNA
shapes. Next, we aimed to control the function of the RNA
aptamer (i.e., ON and OFF) using the L7Ae-induced RNA
structural change. We chose the split RNA aptamer (binary
malachite green aptamer, biMGA)39 and conjugated each split
sequence to the 5′- and 3′-termini of the S-strand in 2Kt-33-Tri
or 2Kt-28-Z (Supplementary Figs 7 and 8). In the presence of
L7Ae, activated (ON) and repressed (OFF) states of the aptamer
should be formed by the assembly and disassembly of two split
RNA fragments through the formation of Tri-shape and Z-shape
RNPs, respectively (Fig. 2h).
To modulate the function of biMGA, we optimized the length
of the linker region between the RNA devices and biMGA, and
the stem sequence of biMGA (Supplementary Figs 9–15 and
Supplementary Note 1). We analysed the function of biMGA on
the designed RNA nanostructures with malachite green (MG) in
the presence and absence of L7Ae by measuring ﬂuorescence
spectra. The interaction between L7Ae and the two optimized
RNA devices (Tri-MGA-ON and Z-MGA-OFF) controlled the
formation of functional RNA aptamers in the ON state and OFF
state, respectively (Fig. 2i). AFM analyses of Tri-MGA-ON and
Z-MGA-OFF conﬁrmed that the modulation of biMGA activity
was indeed due to conformational changes in the designed RNA
devices (Fig. 2j and Supplementary Fig. 16). Thus, we are able to
control both the functions (the activation and repression of the
aptamer) and structures (Tri-shape and Z-shape) of the RNA
nanodevices through detection of the target protein signal.
Actuation of protein-driven RNA nanodevices in living cells.
In cell-signalling pathways, proteins are central to processing



































Fig. 1 Schematic illustration of protein-driven RNA nanodevices in vitro and in mammalian cells. a Protein-triggered conformational change in RNA due to
the L7Ae-K-turn interaction (top) and three-dimensional modeling of the 2Kt-Tri and 2Kt-Z nanostructures (bottom). b Protein-driven RNA nanodevices
that control RNA function in response to proteins. c Actuation of protein-responsive RNA nanodevices that control ﬂuorescence signals within cells.
d Controlling apoptosis by regulating the assembly and oligomerization of apoptosis regulatory proteins on RNA scaffolds
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Fig. 2 Actuation of protein-driven RNA nanodevices in vitro. a Schematic representation of structural changes in 2Kt-33-Tri (left) and 2Kt-28-Z (right)
caused by the induced-ﬁt of RNA in response to L7Ae binding. The distance between the two ends of the RNA is indicated by a red double-headed arrows.
The in silico predicted lengths of each side of 2Kt-33-Tri and 2Kt-28-Z were ~8.7 nm and 7.4 nm, respectively. b, c EMSA conﬁrmed the interaction
between 2Kt-33-Tri (b) and 2Kt-28-Z (c) RNA nanostructures with L7Ae. Higher order bands (black arrowheads) indicate heterogeneous oligomers
composed of L- and S-RNA strands. Concentrations of long and short RNAs: each 50 nM. d, e AFM images of the 2Kt-33-Tri (d) and 2Kt-28-Z (e) RNA
nanostructures in the absence (left) and presence (right) of L7Ae. Scale bars, 20 nm. f, g Statistical distribution of the distance between the two ends of
RNA, indicated by the double-headed arrows in a, for 2Kt-33-Tri (f) and 2Kt-28-Z RNA (g) nanostructures in the absence (black) and presence (red)
of L7Ae (N number of nanostructures). h Schematic illustration of the ON/OFF switching of biMGA activity caused by structural changes in RNA
nanodevices in response to L7Ae binding. Fluorescence emission of Tri-MGA-ON is caused by the formation of an active biMGA that occurs with a
L7Ae-induced RNA conformational change that places two split aptamers close to each other (left). Fluorescence quenching of Z-MGA-OFF is caused by
disassembly of the biMGA that occurs with a L7Ae-induced conformational change that separates the two split aptamers (right). i Fluorescence spectra of
Tri-MGA-ON (left) and Z-MGA-OFF (right) in the absence (black) and presence (green) of L7Ae. j Fraction of open (black) and closed (red) nanostructures
before and after RNP formation (N number of nanostructures). Tri-MGA-ON: Tri-MGA-ON-stem B (Supplementary Fig. 10). Z-MGA-OFF:
Z-MGA-OFF-stem D (Supplementary Fig. 11)
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construct and actuate protein-responsive RNA nanodevices
within live mammalian cells: the RNA nanostructures should
induce a conformational change when detecting a protein
expressed in target cells. We thought that our in vitro designed
Z-shape nanostructures could be used for protein-detector
devices that output ﬂuorescence signals through a speciﬁc RNP
interaction-mediated conformational change in cells (Fig. 3a).
An RNA device with a Cy3- and Cy5-labelled short RNA
duplex at the termini should produce an increase in the
Cy3 signal at 565 nm (F565) and a decrease in the Cy5 signal at
665 nm (F665) by preventing FRET due to the formation of
Z-shape RNP nanostructures. Thus, we ﬁrst optimized the
sequence of the short RNA duplex at the ends of the RNA
devices in vitro by measuring the change in the F565/F665 value
before and after the RNP formation. We engineered 2Kt-17-Z by
introducing Watson–Crick base pairs (from 4 to 8 bp) at the
5′- and 3′-ends of the RNA device (2Kt-17-Z-4, 5, 6, 7 and 8;
Fig. 3a and Supplementary Fig. 17) and measured the
ﬂuorescence spectra of the RNA variants labelled with Cy3 and
Cy5 in the presence and absence of L7Ae (Fig. 3b). The
ﬂuorescence spectra of 2Kt-17-Z-4 and 2Kt-17-Z-5 showed few
changes in the presence of L7Ae. In contrast, for 2Kt-17-Z-6,
2Kt-17-Z-7 and 2Kt-17-Z-8, F565 increased and F665 decreased
simultaneously due to the RNP formation. We found the highest
fold change in the F565/F665 values before and after the RNP
formation when employing 2Kt-17-Z-7 (Fig. 3c). To check size
effects of the RNA nanostructures, we also constructed larger
Z-shape nanostructures, 2Kt-28-Z, with short RNA duplexes
(from 5 to 7 bp) and conﬁrmed that changes in the ﬂuorescence
signal were similar to 2Kt-17-Z (Supplementary Figs 18 and 19).
Thus, we chose 2Kt-17-Z-7 for the following cellular experiments.
To deliver and construct protein-responsive RNA nanostruc-
tured devices inside mammalian cells, we chose the synthetic
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Fig. 3 Actuation of protein-driven RNA nanodevice in vitro and inside live mammalian cells. a Schematic illustration of an intracellular RNA nanodevice that
produces a change in the FRET signal upon detecting protein signals inside live mammalian cells. The in silico predicted lengths of each side of 2Kt-17-Z-X
were ~4.5 nm. b Fluorescence spectra of 2Kt-17-Z-X (X= 4, 5, 6, 7, 8) in the absence (black) and presence (red) of L7Ae in vitro. c Plots of fold change in
F565/F665, [F565/F665 (+ L7Ae)]/ [F565/F665 (− L7Ae)] versus the length of the RNA duplex. d Flow cytometric analysis of the actuation of the RNA
nanodevice by a speciﬁc L7Ae-K-turn interaction within cells. MS2CP- or L7Ae-coding modRNA (500 ng) and 2Kt-17-Z-7 or 2dKt-17-Z-7 RNA nanodevices
(8 pmol) were co-transfected into HeLa cells. Enhancement of the Cy3/Cy5 mean after 12 (left) and 24 (right) hours transfection was calculated from the
Cy3/Cy5 mean intensities of cells transfected with 2Kt-17-Z-7 normalized to the Cy3/Cy5 mean intensity of cells transfected with 2dKt-17-Z-7. The data
are presented as the mean± SD (n = 3). *P< 0.05, **P< 0.01 (Welch’s t-test)
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manipulate cells without random genomic integration40, and
in vitro transcribed RNAs (mRNA that codes a targt protein and
small RNAs to make RNA devices) are directly used to construct
RNP nanostructures in cells. Synthetic RNA devices (2Kt-17-Z-7)
and chemically modiﬁed mRNA (modRNA; the use of modRNA
was expected to reduce the interferon response)40 coding for
L7Ae were co-transfected into HeLa cells. The expression of L7Ae
was conﬁrmed by capillary-based immunodetection
1Kt-33-Tri 3Kt-33-Tri 6Kt-33-Tri 9Kt-33-Tri 14Kt-33-Tri
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(Supplementary Fig. 20). To detect the structural change in RNA
nanodevices inside cells, we performed a ﬂow cytometry-based
FRET assay41 using Cy3- and Cy5-labelled RNA nanodevices
(Fig. 3a and Supplementary Fig. 21). After 12 and 24 h of RNA
transfection, we found that the Cy3/Cy5 signal of 2Kt-17-Z-7
increased in the presence of L7Ae compared with the signal in the
presence of noncognate MS2CP protein or a defective RNA
device
(2dKt-17-Z-7) (Fig. 3d and Supplementary Fig. 21d–g). Although
the enhancement of the signal in the cell was less than that
observed in vitro, these results indicated that the increased
Cy3/Cy5 signal of 2Kt-17-Z-7 was likely due to the conforma-
tional change of the intracellular RNA nanostructure caused by
speciﬁc L7Ae-K-turn interactions. Thus, the protein signal could
actuate the RNA nanostructured device in cell.
RNA scaffold-based cell-fate control by assembling proteins.
We next aimed to control cell fate (i.e., selective cell killing) by
detecting and assembling an apoptosis regulatory protein,
caspase-8 (Casp-8), through speciﬁc RNP interactions on
designed RNA scaffolds formed in target cells. In naturally
occurring systems, Casp-8 contains the death effector domain
(DED), which is responsible for the assembly and activation of
Casp-8 molecules through proximity-induced oligomerization42.
We replaced DED with L7Ae, expecting that the fused L7Ae
should bring multiple Casp-8 catalytic domains together on the
RNA scaffold to induce caspase activation without requirement of
the DED-mediated Casp-8 chain assembly. We therefore fused
L7Ae with DED-defective Casp-8 (dCasp-8) and examined
whether the RNP interaction-mediated accumulation of
L7Ae-dCasp-8 on the RNA scaffold induces cell death (Fig. 1d).
To control the assembly of L7Ae-dCasp-8 on the RNA scaffold,
we newly designed a set of RNA scaffolds that contained 1, 3, 6,
9 or 14 K-turn motifs (1Kt-33-Tri, 3Kt-33-Tri, 6Kt-33-Tri,
9Kt-33-Tri or 14Kt-33-Tri, respectively), which would collect a
different number of L7Ae-dCasp-8 molecules on the RNA
scaffold at nanometre scale (Supplementary Fig. 22).
The speciﬁc RNP interactions between 1-(3-, 6-, 9- or 14-)Kt-
33-Tri and L7Ae were conﬁrmed in vitro by EMSA and AFM
(Fig. 4a and Supplementary Figs 23 and 24). In contrast,
interactions between defective RNA scaffolds with reverse-
complement K-turn motifs (rcKt; they do not interact with
L7Ae; Supplementary Figs 23 and 25) and L7Ae were not.
We found that the structures of the RNA scaffolds were
clearly changed by the L7Ae addition (Supplementary Fig. 24).
Furthermore, we directly observed that the number of L7Ae
proteins assembled on the scaffolds increased as the number of
K-turn motifs on the scaffolds increased (Fig. 4a). We conﬁrmed
L7Ae-dCasp-8 expression in cells by capillary-based immunode-
tection (Supplementary Fig. 26a). We also performed a transla-
tional repression assay40 and conﬁrmed that the fusion of
dCasp-8 to L7Ae maintained L7Ae-K-turn interactions in cells
(Supplementary Fig. 26b, c). To investigate whether the designed
RNA scaffolds could induce cell death through the accumulation
of L7Ae-dCasp-8, each RNA device and L7Ae-dCasp-8-coding
modRNA were co-transfected into HeLa cells and the cells were
analysed by phase microscopy or ﬂow cytometry after 24 h of
transfection. Notably, we observed that 14Kt-33-Tri with
L7Ae-dCasp-8 effectively induced cell death (Fig. 4b, top right
picture and Fig. 4c, left), whereas the defective RNA scaffold
(14rcKt-33-Tri) with L7Ae-dCasp-8 did not (Fig. 4b, bottom right
picture and Fig. 4c, right). This result indicated that L7Ae-dCasp-8
alone does not induce cell death effectively, but the accumulation
of L7Ae-dCasp-8 on the RNA devices facilitates cell-death
induction. In addition, we observed that the dead cell populations
increased as the number of Kt on the RNA scaffolds increased
(9Kt and 14Kt), whereas the number of rcKt on the scaffolds did
not affect cell death (Fig. 4c, d). These results suggest that we can
tune cell-death signals by changing the number of dCasp-8
assembled on the designed RNA scaffold.
To further investigate whether cell death was induced by
Casp-8-mediated apoptosis through speciﬁc RNP interactions,
we constructed inactive variants of Casp-8 by replacing
the catalytically active cysteine residue of Casp-8 with serine
(Casp-8-CS)43 and transfected modRNAs encoding various
protein variants (L7Ae, dCasp-8, L7Ae-dCasp-8, L7Ae-dCasp-8-
CS, Casp-8, L7Ae-Casp-8 and L7Ae-Casp-8-CS) together with
RNA scaffolds (14Kt-33-Tri or 14rcKt-33-Tri) (Fig. 4e and
Supplementary Fig. 27). We conﬁrmed that speciﬁc interactions
between L7Ae-(d)Casp-8 and 14Kt-33-Tri are necessary for the
induction of effective cell death, because L7Ae or (d)Casp-8 alone
did not induce cell death even in the presence of 14Kt-33-Tri
(Fig. 4e and Supplementary Fig. 27). Notably, cell death was
not induced by full-length Casp-8 (or L7Ae-Casp-8) alone,
whereas effective cell death was observed in 14Kt-33-Tri with
L7Ae-Casp-8, indicating that the expression level of Casp-8 from
modRNA is not enough to activate Casp-8 under our experi-
mental condition, but 14Kt-33-Tri could increase the local
concentration of L7Ae-Casp-8 to initiate cell death. This result
suggests that RNA scaffolds may function as a signal ampliﬁer
capable of inducing cell death. In addition, we observed that
14Kt-33-Tri with L7Ae-(d)Casp-8-CS abolished the cell-death
induction, indicating that Casp-8 activity is essential for
triggering apoptosis mediated by the RNP interaction. We
also measured caspase activity using a ﬂuorogenic substrate
(IETD-AMC). The highest caspase activity was observed in
cells transfected with 14Kt-33-Tri and L7Ae-dCasp-8-coding
modRNA, and the addition of a caspase inhibitor (IETD-FMK)
abolished the observed activity (Fig. 4f). Together, these results
conﬁrm that we can selectively control cell-death signalling by
regulating the oligomerization of pro-apoptosis regulatory
proteins on synthetic RNA scaffolds formed in cells.
Next, we designed an alternative RNA scaffold to detect a
different protein signal and control cell fate. Lin28A protein is a
RNA-binding protein that regulates the biogenesis of several
miRNAs (e.g., let-7d miRNA) and has important roles in cancer,
tissue regeneration and the self-renewal of stem cells44.
Fig. 4 Control of mammalian cell fate by the assembly of apoptosis regulatory proteins on synthetic RNA scaffolds. a AFM images of 1, 3, 6, 9 and
14Kt-33-Tri RNA nanostructures in the presence of L7Ae. Scale bars, 10 nm. b, c Microscopic images (b) and ﬂow cytometric analysis (c) of cells that
contain RNA nanostructures and L7Ae-dCasp-8-coding modRNA. Scale bars, 500 µm. The cells were stained with Paciﬁc Blue Annexin V and dead cell
stain, and were analysed using ﬂow cytometry. d Plots of the dead cell population versus the number of Kt (rcKt) motifs. Dead cells were counted by
considering Paciﬁc Blue-positive cells to be dead. e Selective cell death by a speciﬁc RNP interaction between 14Kt-33-Tri and L7Ae-dCasp-8 (or L7Ae-
Casp-8). RNA nanostructures and modRNAs were co-transfected into HeLa cells. Cells stained with Paciﬁc Blue Annexin V were counted as dead cells.
f Caspase ﬂuorometric assay for the detection of caspase activity. The caspase activity of HeLa cells transfected with RNA devices and modRNAs was
measured using a ﬂuorogenic substrate IETD-AMC. IETD-FMK was used as a caspase inhibitor. The data are presented as the mean± SD (n = 3).
**P< 0.01, ***P< 0.001 (Welch’s t-test)
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To develop a Lin28A-responsive cell-killing system with RNP
nanostructures, we constructed Lin28A-fused dCasp-8 (Lin28A-
dCasp-8) and a Lin28A-binding RNA scaffold, 9pre-let7d-33,
by replacing the K-turn motif of 9Kt-33-Tri with pre-let-7d (RNA
sequences derived from let-7d miRNA precursors), which
interacts with Lin28A (Fig. 5 and Supplementary Fig. 28). We
expected that the RNP interaction between Lin28A-dCasp-8 and
9pre-let7d-33 would induce cell death in a similar manner to
L7Ae-dCasp-8 and 9Kt-33-Tri (Fig. 5a, left). Conversely, in cells
that express Lin28A, the effect of cell death should be modulated
by competitive binding between Lin28A and Lin28A-dCasp-8 to
9let7d-33, which should reduce the level of Casp-8 activation on
the RNA scaffold (Fig. 5a, right). Transfection of 9pre-let7d-33
with Lin28A-dCasp-8-coding modRNA to HeLa cells showed
effective cell death comparable to the effect of 9Kt-33-Tri with
L7Ae-dCasp-8-coding modRNA, whereas Lin28A-dCasp-8 or
9pre-let7d-33 alone did not induce cell death, conﬁrming that the
RNP interaction is essential for triggering cell death. In addition,
we observed that co-transfection of Lin28A-coding modRNA
together with 9pre-let7d-33 and Lin28A-dCasp-8-coding mod-
RNA reduced the number of dead cells (Fig. 5b), suggesting that
Lin28A competes with Lin28A-dCasp-8 to bind 9pre-let7d-33.
We also conﬁrmed the expression of Lin28A and Lin28A-dCasp-8 in
cells by capillary-based immunodetection (Supplementary Fig. 29).
To further investigate whether the system could selectively
control cell fate by detecting endogenous expression levels of
Lin28A, we constructed a stable HeLa-Lin28A cell line that
expresses Lin28A from the genome (Supplementary Fig. 29). We
compared Lin28A expression levels in HeLa-Lin28A and human
induced pluripotent stem cells (hiPSCs, 201B7) that express
endogenous Lin28A. We found that the Lin28A expression level
in HeLa-Lin28A was lower than that in hiPSCs (Supplementary
Fig. 30), suggesting HeLa-Lin28A cells do not express Lin28A
beyond endogenous levels. We next transfected either 9pre-let7d-
33 with Lin28A-dCasp-8-coding modRNA or 9Kt-33-Tri with
L7Ae-dCasp-8-coding modRNA to HeLa-Lin28A cells (Fig. 5c).
We observed that cells treated with 9pre-let7d-33 with Lin28A-
dCasp-8 did not induce cell death, whereas cells treated with
9Kt-33-Tri with L7Ae-dCasp-8 increased the number of dead
cells. These results indicate that cell-death signals initiated by
9pre-let7d-33 with Lin28A-dCasp-8 can be attenuated when
Lin28A is detected in the cell. In addition, we transfected these
RNA nanodevices in hiPSCs and found that Lin28A-dCasp-8
with 9pre-let7d-33 did not induce cell death, whereas L7Ae-
dCasp-8 with 9Kt-33-Tri did in a manner similar to that in HeLa-
Lin28A cells (Fig. 5d and Supplementary Fig. 31). Based on these
results, we concluded that RNA-scaffold mediated cell-death
control is adaptable to not only the L7Ae-K-turn interaction, but
also the Lin28A-pre-let-7d interaction.
9pre-let7d-33
Lin28A-dCasp-8
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Fig. 5 RNA scaffold-mediated cell-death control by Lin28A detection. a Schematic representation of a Lin28A-responsive RNA nanostructured device
composed of 9pre-let7d-33 and Lin28A-dCasp-8. b Lin28A-responsive control of cell fate using 9pre-let7d-33 and Lin28A-dCasp-8 in HeLa cells.
L7Ae-responsive 9Kt-33-Tri was used as a control. Cell death is induced in the presence of both 9pre-let7d-33 and Lin28A-dCasp-8. The induction of cell
death is partially repressed by adding Lin28A-coding modRNA as a competitor. c, d Selective cell-fate control by detecting Lin28A in HeLa-Lin28A cells (c)
and hiPSCs (d). Dead cells were stained with Paciﬁc Blue Annexin V and analysed using ﬂow cytometry. The data are presented as the mean± SD (n = 3).
NS not signiﬁcant, *P< 0.05, **P< 0.01 (Welch’s t-test)
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Actuation of protein-driven RNA devices by miRNA signals.
Finally, in order to detect intracellular RNA signals and actuate
protein-responsive RNA nanodevices, we constructed a system
that responds to endogenous miRNAs and regulates Casp-8
protein signals. We designed synthetic mRNA45 that controls
L7Ae-dCasp-8 expression in response to endogenous miRNAs
expressed in target cells (miR-L7Ae-dCasp-8 switch). We linked
this switch to an RNA device, 14Kt-33-Tri (Fig. 6a). To selectively
control cell-death signals through miRNA detection, we applied
our system to HeLa cells and hiPSCs, which express active miR-
21-5p (miR-21) and miR-302a-5p (miR-302), respectively.
Accordingly, we designed miR-21- and miR-302-responsive
L7Ae-dCasp-8 mRNA switches. Transfection of miR-21 (miR-
302)-L7Ae-dCasp-8 switch with the defective RNA scaffold
(14rcKt-33-Tri) did not induce cell death in either cell type
(Fig. 6b, c), indicating that miR-L7Ae-dCasp-8 switch without the
correct RNA scaffold cannot trigger cell death. On the other
hand, miR-302-L7Ae-dCasp-8 switch with 14Kt-33-Tri efﬁciently
and selectively induced HeLa cell death but not hiPSC death
(Fig. 6b) and miR-21-L7Ae-dCasp-8 switch with 14Kt-33-Tri
selectively induced hiPSC death but not HeLa cell death (Fig. 6c).
These results suggest that L7Ae-dCasp-8 protein assembly on
14Kt-33-Tri is essential to initiate cell death. In addition,
we observed an increased level of dead cells by the addition of
miR-302 or miR-21 inhibitors with the corresponding switches in
hiPSCs and HeLa cells, respectively (Fig. 6b, c), indicating that
endogenous miR-302 and miR-21 can control cell-death signals
activated by the formation of RNP nanostructures. We also
observed that the addition of a miR-302 or miR-21 mimic with
the corresponding switches repressed the death of HeLa cells and
hiPSCs, respectively (Fig. 6b, c). Together, these results suggest
that we can control RNA scaffold-mediated cell death by
detecting endogenous miRNAs and modulating protein signals in
target cells.
Discussion
In this study, we demonstrated the construction of protein-
triggered, functional RNA nanostructured devices in vitro and
within mammalian cells. Both the structures and the functions of
the devices can be controlled via speciﬁc RNP interactions,
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Fig. 6 RNP nanodevices that detect endogenous miRNAs and selectively control cell-death signals. a Schematic representation of miRNA-responsive cell-
death control mediated by miRNA switches encoding L7Ae-dCasp-8 and RNA scaffolds. b, c Cell-death induction using miR-302 (b) and miR-21 (c)
responsive switches encoding L7Ae-dCasp-8 and 14Kt-33-Tri (14rcKt-33-Tri) in HeLa cells (blue) and hiPSCs (red). The dead cells were stained with Paciﬁc
Blue Annexin V and analysed using ﬂow cytometry. The data are presented as the mean± SD (n = 3). **P< 0.01 (Welch’s t-test)
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aptamer formation, intracellular protein-responsive actuation and
cell-fate control by detecting intracellular protein or miRNA
signals). Protein-responsive RNA-nanostructured devices may
regulate various biological processes, because the spatiotemporal
regulation of naturally occurring RNP complexes has a crucial
role in the control of gene expressions, signal transductions and
cell-fate conversions.
Our system provides a tool for controlling the localization and
accumulation of signal proteins on RNA scaffolds that were
designed on a nanometre scale. In fact, we found that the oli-
gomerization of L7Ae-dCasp-8 proteins (i.e., more than nine
dCasp8 proteins) on a designed RNA scaffold is important for the
induction of effective cell death. In naturally occurring systems,
the assembly and activation of Casp-8 are induced by the for-
mation of death-inducing signalling complex (DISC), which is a
key step in the death receptor-mediated activation of apoptotic
pathways. Dickens et al.46 reported that DISC contains ninefold
more Casp-8 than Fas-associated protein with death domain
(FADD) and they proposed a DED chain assembly model for
DISC formation. They demonstrated that the recruitment of
many Casp-8 molecules to a single FADD molecule was required
for DISC formation and subsequent apoptotic cell death. The
DISC model seems to agree well with our observation that the
assembly of more than nine L7Ae-dCasp-8 proteins on a single
RNA scaffold facilitated effective Casp-8 activation and cell-death
induction (Fig. 4). To further examine the effect of RNA
structural conﬁguration on cell-killing activity, we designed an
alternative scaffold that formed ‘zigzag-shaped’ nanostructures
(14Kt-27,28-Zig) by RNP interaction (Supplementary Fig. 32).
The cell-killing activity of 14Kt-27,28-Zig was comparable to that
of 14Kt-33-Tri (Supplementary Fig. 33), suggesting that the
assembly and oligomerization of dCasp-8 proteins on the RNA
scaffolds are important for cell-death induction.
The molecular design of RNA nanodevices can be applied to
various RNA motifs that bind to target proteins, including
naturally occurring motifs and in vitro selected aptamers. Indeed,
we designed and constructed alternative RNA nanodevices that
control their structures by responding to U1A protein by
employing U1A-binding motifs47 (Supplementary Fig. 34). We
observed that U1A protein interacted with the RNA device to
induce RNA conformational change (Supplementary Fig. 35). To
actuate RNA nanodevices in response to a target protein within
mammalian cells, RNA-binding proteins of interest (e.g., Lin28A)
could be fused to functional proteins (e.g., dCasp-8) and the
protein-binding RNA motifs can be incorporated into the RNA
nanodevices. We designed a Lin28A-resposive, cell-fate control
system using the 9pre-let7d-33 nanodevice (Fig. 5). We found
that Lin28A expressed in HeLa-Lin28A cells or hiPSCs inhibited
Lin28A-dCasp-8-mediated cell killing activity, probably due to
the competitive binding between Lin28A and Lin28A-dCasp-8 to
9pre-let7d-33. These data suggest that the RNA scaffold-mediated
cell death system could be modular and controllable by detecting
various protein signals.
To detect endogenous miRNAs and control protein signals on
the RNA scaffold, we combined our protein-responsive RNA
nanostructured devices with miRNA-responsive mRNAs (miR-
switches)45. The combination of 14Kt-33-Tri and miR-L7Ae-
dCasp-8 switch selectively induced cell death in HeLa cells or
hiPSCs by responding to the endogenous miRNA signatures
(miR-21 or miR-302) and by regulating Casp-8-mediated apop-
tosis signals on the RNA scaffold. Transfection of full-length
Casp-8- or L7Ae-Casp-8-encoding mRNA did not induce cell
death (Fig. 4e), indicating that simple use of miRNA switches that
express Casp-8 cannot control the cell phenotype efﬁciently. In
contrast, RNA scaffold 14Kt-33-Tri ampliﬁed cell-death signals
produced from miR-L7Ae-dCasp-8 switch and increased the
number of dead cells in the absence of the target miRNAs. We
propose that the combination of miRNA switches and synthetic
RNA scaffolds can facilitate the control of miRNA-responsive
cell-signalling pathways for the following reasons: (1) the simple
use of miRNA switches that encode cell-death inducers may cause
leaky expression of the proteins even in the presence of miRNA,
which could blur the threshold between different cell types,
because the expression balance between miR-switches and
miRNA is critical for controlling cell death; (2) synthetic RNA
scaffolds that assemble and oligomerize target proteins at nan-
ometer scale can amplify the effect of protein signals by
increasing the local concentration of the proteins on the scaffold:
signal ampliﬁcation processes using RNA scaffolds facilitate to
control cell fate; and (3) RNA scaffolds can tune the signals by
changing the assembly number of the apoptosis regulatory pro-
teins on the scaffold (Fig. 4a–d).
To develop functional nanodevices in mammalian cells for
future therapeutic applications, the introduction and formation of
nanostructures inside target cells should be safe and efﬁcient.
Thus, we thought that the formation of RNP nanostructures in
cells by RNA-only delivery is ideal for the following reasons:
(1) the gene delivery of synthetic RNA rather than DNA is more
likely to avoid potential genomic damage caused by random
genomic integration of devices40; (2) modRNA can produce
RNA-binding proteins without an immune response40; (3) the
function of RNA devices can be transiently actuated inside cells,
reducing the risk of potential side effects; and (4) the self-folding
of RNA strands in vitro before transfection may facilitate the
efﬁcient detection of intracellular proteins via RNP interactions in
the cytoplasm and the subsequent control of cell functions,
because neither transcription nor RNA export from the nucleus
are required in the case of RNA delivery; (5) RNA delivery
approaches may have diverse medical applications, such as RNA
vaccines48, cell reprogramming49, cell puriﬁcation45 and cell-fate
control40.
The construction of protein-responsive nucleic acid nanode-
vices in vitro has been reported. Examples of such nanodevices
include nanomechanical DNA origami that detects proteins at the
single-molecule level8, DNA nanorobots that recognize the cell
surface and control cell signalling by utilizing the interaction
between DNA aptamers and protein10, and protein-triggered
DNA nanomachines on gold nanoparticles that control the
assembly and cleavage of DNA components50. However, the
detection of proteins by DNA nanodevices has been limited to
in vitro or cell surfaces. Protein-assembled RNA nanostructures
have also been constructed in vitro31–34, although these RNA
nanostructures had rather static scaffolds and their conforma-
tions and functions were not controlled by the protein signal.
Our RNA nanostructured devices can be actuated via their
conformational changes both in vitro and inside mammalian cells
in response to extracellular and intracellular protein signals,
respectively. In addition, our RNA devices are signal transducers
that are capable of converting the input protein signal into the
work of RNA (e.g., the formation of active aptamers) or protein
(e.g., apoptosis induction) by employing a dynamic RNA scaffold.
We believe that RNA and RNP nanodevices can be employed
as a material to construct molecular robots that regulate their
structures and produce desired functions by sensing various types
of extracellular and intracellular information.
Methods
Plasmid construction. DNA templates of 14Kt-33-Tri-long and 14Kt-33-Tri-short
and 14Kt-27,28-Zig-long and 14Kt-27,28-Zig-short with BamHI and XbaI sites
were purchased from Life Technology. Preparation of 9pre-let7d-33-long
plasmid was delegated to FASMAC. The DNA templates were inserted into
the BamHI–XbaI sites of pcDNA4/TO to give the desired plasmids. We used
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pcDNA3.1-L7Ae-myc-His6 and pBS-mFLICE51 (or pCSII-EF-Flag-mCasp8
CS-IRES-GFP43) for the construction of L7Ae-dCasp-8 and L7Ae-Casp-8
(or L7Ae-dCasp-8-CS and L7Ae-Casp-8-CS) plasmids. The dCasp-8 and full length
Casp-8 was ampliﬁed from pBS-mouse Casp-8 by PCR using the corresponding
primer sets, digested with EcoRI and XhoI, and inserted into the EcoRI–XhoI site of
pcDNA3.1-L7Ae-myc-His6 to give pcDNA3.1-L7Ae-dCasp-8-myc-His6,
pcDNA3.1-L7Ae-Casp-8-myc-His6 and the corresponding CS mutants. Lin28A
was ampliﬁed from pLIN28Amyc-T2A-tagRFP by PCR using Lin28A-Fwd and
Lin28A-Rev, digested with EcoRI and NotI, and inserted into the EcoRI–NotI site of
pcDNA3.1-L7Ae-dCasp-8-myc-His6 to give pcDNA3.1-Lin28A-dCasp-8-myc-
His6.
DNA and RNA preparation for constructing RNA nanostructures. DNA tem-
plates and primers were purchased from Greiner Japan. DNA templates for in vitro
transcription were prepared by PCR using KOD-Plus-Neo DNA Polymerase
(TOYOBO). The DNA templates were puriﬁed using a MinElute PCR Puriﬁcation
Kit (QIAGEN), according to the manufacturer’s protocol. RNAs were transcribed
by a MEGAshortscript Kit (Ambion), according to the manufacturer’s protocols.
The transcribed RNAs were puriﬁed by denaturing polyacrylamide gel electro-
phoresis (PAGE). After the recovery of the RNAs, the RNA concentration was
measured using NanoDrop (Thermo Scientiﬁc). The DNA templates of 1Kt-33-Tri
and 1rcKt-33-Tri were generated by PCR using synthetic oligo-DNAs. The DNA
templates of 3, 6, 9 and 14Kt-33-Tri, and the corresponding mutants (3, 6, 9 and
14rcKt-33-Tri) were ampliﬁed from pcDNA4/TO-14Kt-33-Tri by PCR using the
corresponding primer sets. The DNA templates were transcribed using a
MEGAshortscript Kit (Ambion) and a modiﬁed protocol. Psuedouridine-5’-
triphosphate and 5-methylcytidine-5’-triphosphate (TriLink BioTechnology)
were used instead of uridine-5’-triphosphate and cytidine-5’-triphosphate. The
transcription of 9pre-let7d-33 was conducted with only cytosine modiﬁcation to
maintain the RNP interaction between pre-let-7d and Lin28A. Reaction mixtures
were incubated at 37 °C for 4–16 h. TURBO DNase (Ambion) was added to the
reaction mixtures to remove template DNAs. After incubation at 37 °C for 30 min,
the RNAs were puriﬁed using a FavorPrep Blood/Cultured Cells total RNA
extraction column (Favorgen Biotech) and then treated with Antarctic Phosphatase
(New England Biolabs). After incubation at 37 °C for 30 min, the resulting RNAs
were puriﬁed by an RNeasy MinElute Cleanup Kit (QIAGEN) and denaturing
PAGE.
Preparation of DNA template for modRNA synthesis. The 5′- and 3′-
untranslated regions (UTRs) were generated by using PCR with the proper sets of
synthetic oligo-DNAs. The protein-coding regions of the desired proteins were
prepared by PCR with the corresponding protein-containing plasmids using proper
primer sets. The template plasmids were digested with the DpnI restriction enzyme
(TOYOBO) for 30 min at 37 °C. The PCR products were puriﬁed using a MinElute
PCR Puriﬁcation Kit (QIAGEN), according to the manufacturer’s protocol. DNA
templates for modRNA synthesis were generated by PCR using the primer set
T7FwdG3C (0.3 µM) and Rev120A (0.3 µM) and using the PCR products of the 5′-
UTR PCR (10 nM), 3′-UTR PCR (10 nM), and a coding region (0.2 ng µl−1). DNA
templates for enhanced green ﬂuorescent protein (EGFP)-myc-coding modRNA
synthesis were generated by PCR using the primer set CGCT7G2 (0.3 µM) and
Rev120A (0.3 µM), the PCR products of 5′-UTR PCR (10 nM) and an EGFP
coding region. DNA templates for miRNA-responsive modRNAs (miRNA
switches) were prepared by using the PCR products of miRNA target site-
containing 5′-UTR (5′-UTR-T21-5p PCR or 5′-UTR-T302a-5p PCR) instead of the
above 5′-UTR PCR. The PCR products were puriﬁed with the above-mentioned
protocol.
Preparation of modRNAs. mRNAs were generated from the corresponding DNA
templates using a MEGAscript T7 Kit (Ambion) and a modiﬁed protocol. Psue-
douridine-5’-triphosphate and 5-methylcytidine-5’-triphosphate (TriLink Bio-
Technology) were used instead of uridine-5’-triphosphate and cytidine-5’-
triphosphate. A mixture of Anti-Reverse Cap Analog (TriLink) and guanosine-5’-
triphosphate (4:1) was used instead of guanosine-5’-triphosphate. Reaction mix-
tures were incubated at 37 °C for 4 h and then treated with TURBO DNase
(Ambion) at 37 °C for 30 min. The RNAs were puriﬁed using a FavorPrep Blood/
Cultured Cells total RNA extraction column (Favorgen Biotech) and then treated
with Antarctic Phosphatase (New England Biolabs) at 37 °C for 30 min. The
resulting mRNAs were puriﬁed using an RNeasy MinElute Cleanup Kit
(QIAGEN).
Cy3- and Cy5-labelling of RNA. Cy3- and Cy5-labelled RNAs were prepared by
ligation using T4 RNA ligase (Ambion), pCp-Cy3 (Jena Bioscience) and pCp-Cy5
(Jena Bioscience). Cy3- and Cy5-labelling was performed with 150 pmol RNA
using 10 U T4 RNA ligase, 3 nmol pCp-Cy3 or pCp-Cy5 and 10% (v/v) dimethyl
sulfoxide in 10 µl at 16 °C for 36–48 h. The Cy3- and Cy5-labelled RNAs were
puriﬁed using an RNeasy MinElute Cleanup Kit (Qiagen). After the recovery of
RNAs, the RNA concentration was measured in a NanoDrop (Thermo Scientiﬁc).
The labelling efﬁciencies of Cy3 and Cy5 were calculated from the absorbance of
Cy3 and Cy5, respectively.
Electrophoretic mobility shift assay. Mixtures of L-RNA and S-RNA (each
20–50 nM) in 20 mM phosphate buffer, pH 7.0, 1.5 mM MgCl2 and 150 mM KCl
were heated at 80 °C for 3 min and then cooled at room temperature for 10 min.
After the addition of L7Ae (50–1000 nM), the mixtures were incubated at room
temperature for 10–30 min. The mixtures were mixed with 10 × loading buffer
(0.25% bromophenol blue, 30% glycerol) and were subjected to electrophoresis
through a native polyacrylamide gel with 0.5 × Tris/Borate/EDTA buffer at room
temperature. After electrophoresis, the gels were stained for 10 min with SYBR
Green I and II (Lonza). Images of the gels were collected using a Gel Doc EZ
Imager (BIO-RAD) or a Typhoon FLA 7000 laser scanner (GE Healthcare).
Atomic force microscopy. The RNA and RNP nanostructures were observed in
solution. Their samples were prepared as described for the EMSA. The AFM
images were collected using Nano Live Vision (Research Institute of Biomolecules
Metrology Co.) or BIXAM (Olympus). Small cantilevers (9 µm long, 2 µm wide and
130 nm thick; BL-AC10EGS, Olympus) having a spring constant of ~0.1 Nm−1 and
a resonant frequency of ~300–600 kHz in water were used to scan the sample
surface. The 320 × 240-pixel images were collected at a scan rate of 0.2 frames
per second. A fresh mica surface was coated with 0.1% 3-aminopropyltriethoxy
silane. The samples (20–50 nM RNA nanostructure with or without 600–1,000 nM
protein) were prepared in RNP binding buffer and diluted ﬁve- (for RNP nanos-
tructures) or tenfold (for RNA nanostructures) with AFM observation buffer (20
mM Tris-HCl (pH 7.6) and 10 mM MgCl2). Then, they were applied to the mica
for 5 min at room temperature and were washed with buffer solution. The image
sequences were analysed using ImageJ (http://imagej.nih.gov/ij/) software.
FRET experiment. Cy3- and Cy5-labelled RNAs (each 50 nM) were heated at 80 °
C for 3 min and then cooled at room temperature for 10 min in 20 mM phosphate
buffer (pH 7.0) containing 1.5 mM MgCl2 and 150 mM KCl. Tween-20 (0.1%) and
either protein buffer (20 mM phosphate buffer, pH 7.0, 1.5 mM MgCl2, 150 mM
KCl and 40% glycerol) or L7Ae (600 nM) dissolved in protein buffer was added to
the mixtures and incubated at room temperature for 10–30 min. The excitation
wavelength was 512 nm and the emission and excitation bandwidths were 10 nm.
Fluorescence measurements were carried out with Inﬁnite M1000 Plate Reader
(TECAN).
Fluorescence measurement of biMGA. biMGA-conjugated RNA nanostructures
(100 nM) were heated at 80 °C for 3 min and then cooled at room temperature
for 10 min in 20 mM phosphate buffer (pH 7.0) containing 1.5 mM MgCl2 and
150 mM KCl. MG (2 µM), Tween-20 (0.1%) and either protein buffer (20 mM
phosphate buffer, pH 7.0, 1.5 mM MgCl2, 150 mM KCl and 40% glycerol) or L7Ae
(600 nM) dissolved in protein buffer were added to the mixtures and incubated at
room temperature for 10–30 min. The excitation wavelength was 610 nm and the
emission and excitation bandwidths were 10 and 20 nm, respectively. Fluorescence
measurements were carried out with Inﬁnite M1000 Plate Reader (TECAN).
Cell cultures. HeLa cells (originally obtained from ATCC) were cultured at 37 °C
in 5% CO2 in Dulbecco’s modiﬁed Eagle’s medium–High Glucose (Nacalai Tesque)
containing 10% fetal bovine serum (Japan Bio Serum), non-essential amino acids
(Invitrogen), sodium pyruvate (Sigma) and antibiotic antimycotic solution (Sigma).
HeLa cells stably expressing Lin28A (a kind gift from Dr. Kozo Tomita, Tokyo
University) were established by transfecting pIRES-puro vector containing Flag-
tagged Lin28A sequence into HeLa cells. Positive clones were obtained by selection
with puromycin (0.5 μg ml−1) for 2 weeks. Human iPS cells (201B7, a kind gift
from Dr Masato Nakagawa, Kyoto University) were maintained in feeder-free
condition52 with StemFit AK03 (Ajinomoto) on laminin-511 E8 (iMatrix-511,
Nippi).
RNA transfection. Mixtures of L-RNA and S-RNA (each 0.1–4 μM) in 20 mM
phosphate buffer, pH 7.0, 1.5 mM MgCl2 and 150 mM KCl were heated at 80 or
95 °C for 3 min and then cooled at room temperature for 10 min. The mixtures of
RNA nanostructures (0.1–8 pmol) and modRNAs (10–500 ng) were used for RNA
delivery using Stemfect RNA Transfection Reagent (STEMGENT) according to the
manufacturer’s protocol.
Flow cytometric-based FRET assay. A total of 5 × 104 cells were seeded into
12-well plates. After a 24 h culture, RNA nanodevices (8 pmol) and modRNA
(500 ng) were co-transfected into the cells using 2 µl of Stemfect RNA Transfection
Reagent (STEMGENT). The medium was changed after 2 h. After 12 or 24 h of
transfection, the cells were washed with phosphate-buffered saline (PBS) and
incubated in 200 µl of 0.25% Trypsin-EDTA (Nacalai Tesque) at 37 °C for 3 min.
After the addition of 100 µl of Dulbecco’s PBS containing 2% fetal bovine serum,
the cells were analysed with a FACSAria cell sorter (BD Bioscience). A 532 nm laser
and a 575/25 nm optical ﬁlter were used to detect Cy3 ﬂuorescence. A 532 nm laser
and a 670/30 nm optical ﬁlter were used to detect the Cy5 ﬂuorescence attributed
to FRET. In the ﬂow cytometric analysis, dead cells were removed using a dot
plot of forward scatter (FSC) versus side scatter (SSC). The evaluation of the FRET
signal change by the actuation of an RNA nanodevice was performed by calculating
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the mean of the ratio between the Cy3 and Cy5 ﬂuorescence intensities.
Enhancement of the Cy3/Cy5 mean was calculated from the Cy3/Cy5 mean nor-
malized to cells transfected with 2dKt-17-Z-7 and either MS2CP- or L7Ae-coding
modRNA. The obtained means were normalized to the mean of negative control
cells transfected with MS2CP-conding modRNA and 2dKt-17-Z-7 for calculating
relative Cy3/Cy5 mean intensities.
Cell-death assay. A total of 5 × 104 cells were seeded into 24-well plates. After a
24 h culture, the corresponding RNA nanostructures (0.1 pmol) and modRNA
(10 ng) were co-transfected into the cells using 1 µl of Stemfect RNA Transfection
Reagent (STEMGENT). After 2 h, the medium was changed. Cell images were
taken after 24 h of transfection. The supernatants and cells were recovered and
stained with Paciﬁc Blue-labelled Annexin V (Life Technologies). Dead cells were
stained with SYTOX AADvanced Dead Cell stain (Life Technologies), if needed.
The stained cells were analysed using a FACSAria cell sorter and LSR Fortessa (BD
Bioscience). A 405 laser and a 488 nm laser were used for the excitation of Paciﬁc
Blue and SYTOX AADvanced Dead Cell Stain, respectively; 450/50 and 660/20 nm
optical ﬁlters were used to detect the ﬂuorescence of Paciﬁc Blue and SYTOX
AADvanced Dead Cell Stain, respectively. Cells with high Paciﬁc Blue ﬂuorescence
intensity were counted as apoptotic and dead cells.
miRNA-responsive cell-death regulation assay. A total of 5 × 104 cells (HeLa
cells and hiPSCs) were seeded into 24-well plates. After a 24 h culture, the
corresponding RNA nanostructure (0.1 pmol for HeLa cells and 0.2 pmol for
hiPSCs) and miRNA-responsive modRNA switch (10 ng for HeLa cells and 30 ng
for hiPSCs) were transfected into the cells using 1 µl of Stemfect RNA Transfection
Reagent (STEMGENT). MiR-21-5p inhibitor (2 pmol) and miR-302a-5p mimic
(0.5 pmol) were used for HeLa cells. MiR-21-5p mimic (2 pmol) and miR-302a-5p
inhibitor (2 pmol) were used for hiPSCs. The following protocols were similar to
‘Cell-death assay.’
Lin28A-responsive cell-death regulation assay. A total of 5 × 104 cells (HeLa
cells, HeLa-Lin28A cells and hiPSCs) were seeded into 24-well plates. After a 24 h
culture, the corresponding RNA nanostructures (0.2 pmol for HeLa cells and HeLa-
Lin28A cells, 0.4 pmol for hiPSCs) and Lin28A-dCasp-8 (40 ng for HeLa cells,
HeLa-Lin28A cells and hiPSCs)- or L7Ae-dCasp-8 (10 ng for HeLa cells, HeLa-
Lin28A cells, 30 ng for hiPSCs)-coding modRNA were co-transfected into the cells
using 1 µl of Stemfect RNA Transfection Reagent (STEMGENT). Lin28A- or
MS2CP-coding modRNA (40 ng for HeLa cells) was used as a competitor for the
data in Fig. 6b. The following protocols were similar to ‘Cell-death assay.’
Measurement of caspase activity. A total of 2 × 105 HeLa cells were seeded into
six-well plates and incubated for 24 h. The corresponding RNA nanostructures
(0.4 pmol) and modRNA (40 ng) were co-transfected to the cells using 4 µl of
Stemfect RNA Transfection Reagent (STEMGENT). After 2 h, the medium was
changed. The measurement of caspase activity was performed after 6 h of trans-
fection. The caspase activity was measured using an APOPCYTO Casp-8 Fluoro-
metric Assay Kit (MBL), according to the manufacturer’s protocol. IETD-AMC
(100 μM) and IETD-FMK (10 μM) were used as caspase substrate and inhibitor,
respectively.
Translational repression assay. A total of 5 × 104 HeLa cells were seeded into
24-well plates and incubated for 24 h. K-turn (Kt) motif-containing EGFP
(Kt-EGFP)-coding modRNA (100 ng) and a mixture of L7Ae- or L7Ae-dCasp-8-
coding modRNA with MS2CP-coding modRNA (total 250 ng) were co-transfected
into the cells using 1 µl Stemfect RNA Transfection Reagent (STEMGENT). The
medium was changed after 2 h. After 24 h transfection, the cells were recovered
after Trypsin-EDTA treatment and analysed with LSR Fortessa (BD Bioscience).
A 488 nm laser and a 530/30 nm optical ﬁlter were used to detect EGFP ﬂuores-
cence. In the ﬂow cytometric analysis, dead cells were removed using a dot plot of
FSC versus SSC. The evaluation of translational repression was performed by
calculating the mean of the EGFP ﬂuorescence intensities. The obtained means
were normalized to the mean of cells transfected with Kt-EGFP-coding modRNA
(100 ng) and MS2CP-coding modRNA (250 ng).
Immunodetection of proteins. A total of 2 × 105 cells were seeded into six-well
plates. Cells transfected with various amounts of modRNAs encoding L7Ae-myc-
His6, L7Ae-dCasp-8-myc-His6 and Lin28A were prepared in a similar manner as
described in Cell-death assay using 4 μl Stemfect RNA Transfection Reagent
(STEMGENT). After 24 h transfection, the supernatant and adhesive cells were
collected and washed by PBS. The collected cells were lysed in M-PER Mammalian
Protein Extraction Reagent (Thermo) for 5 min, then the debris of the cells were
removed by centrifugation. The total amount of protein in the supernatant was
determined by BCA assay kit (Thermo). GAPDH, Myc-tag and Lin28A were
detected by an automated capillary-based immunodetection system (Wes
SimpleWestern, ProteinSimple) using 100-fold diluted Anti-GAPDH (Santa Cruz,
FL-355, sc-25778), 20-fold diluted Anti-Myc (Santa Cruz, sc-789) and 100-fold
diluted Anti-Lin28A (R&D Systems, AF3757) antibodies as primary antibodies,
respectively. HRP-conjugated Anti-rabbit (ProteinSimple, 042-206) and 100-fold
diluted Anti-goat (Thermo, 81-1620) antibodies were used as secondary antibodies.
The expression levels of the target proteins were quantiﬁed by Compass software
(ProteinSimple).
Statistical analysis. The statistical signiﬁcance was analysed by Welch’s t-test
(KaleidaGraph 4.5.1, HULINKS). The levels of signiﬁcance are denoted as
*P< 0.05, **P< 0.01, ***P< 0.001, NS not signiﬁcant. All data are presented as the
mean± SD.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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